Open Access
Endosc Int Open 2016; 04(01): E24-E29
DOI: 10.1055/s-0034-1393124
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Effect of additional surgery after noncurative endoscopic submucosal dissection for early gastric cancer

Kohei Yamanouchi
1   Department of Internal Medicine & Gastrointestinal Endoscopy, Saga Medical School, Saga 849-8501, Japan
,
Shinichi Ogata
2   Department of Gastroenterology, Saga Prefectural Medical Centre Koseikan, Saga 840-8571, Japan
,
Yasuhisa Sakata
1   Department of Internal Medicine & Gastrointestinal Endoscopy, Saga Medical School, Saga 849-8501, Japan
,
Nanae Tsuruoka
1   Department of Internal Medicine & Gastrointestinal Endoscopy, Saga Medical School, Saga 849-8501, Japan
,
Ryo Shimoda
1   Department of Internal Medicine & Gastrointestinal Endoscopy, Saga Medical School, Saga 849-8501, Japan
,
Atsushi Nakayama
1   Department of Internal Medicine & Gastrointestinal Endoscopy, Saga Medical School, Saga 849-8501, Japan
,
Takashi Akutagawa
1   Department of Internal Medicine & Gastrointestinal Endoscopy, Saga Medical School, Saga 849-8501, Japan
,
Shimpei Shirai
2   Department of Gastroenterology, Saga Prefectural Medical Centre Koseikan, Saga 840-8571, Japan
,
Eri Takeshita
1   Department of Internal Medicine & Gastrointestinal Endoscopy, Saga Medical School, Saga 849-8501, Japan
,
Koji Yamamoto
2   Department of Gastroenterology, Saga Prefectural Medical Centre Koseikan, Saga 840-8571, Japan
,
Kazuma Fujimoto
1   Department of Internal Medicine & Gastrointestinal Endoscopy, Saga Medical School, Saga 849-8501, Japan
,
Ryuichi Iwakiri
1   Department of Internal Medicine & Gastrointestinal Endoscopy, Saga Medical School, Saga 849-8501, Japan
› Institutsangaben
Weitere Informationen

Publikationsverlauf

submitted 13. April 2015

accepted after revision 18. August 2015

Publikationsdatum:
27. November 2015 (online)

Preview

Background and study aims: Endoscopic submucosal dissection (ESD) is a standard treatment for early gastric cancer (EGC) without lymph node metastasis. However, some patients undergo noncurative ESD. The aim of the present study was to assess the long-term clinical outcomes of noncurative ESD with or without additional surgery.

Patients and methods: We investigated the chart data from all patients who had undergone ESD for EGC at Saga Medical School Hospital and Saga Prefectural Medical Centre Koseikan between 2001 and 2012. A total of 957 cases (1047 lesions) of EGC underwent ESD, and 99 had noncurative ESD. In total, 20 cases were excluded because their follow-up period was < 3 years. We divided the patients into observation and additional surgery groups, and we compared the survival rate and related factors between the groups.

Results: After noncurative ESD, 28 /79 patients (35.4 %) underwent additional surgery and 51/79 (64.6 %) were followed up without surgery. The average age of patients in the observation group was higher than that of the additional surgery group (75.9 vs. 71.6 years; P = 0.03). The incidence of hypertension was significantly higher in the observation group compared with the additional surgery group (51.0 vs. 25.9 %; P = 0.03). The overall survival rate of the additional surgery group was longer than that of the observation group. However, only one patient died from gastric cancer in the observation group. The disease-specific survival rate did not differ significantly between the groups.

Conclusions: It might be acceptable to follow up without additional surgery for some patients with comorbidity and who were elderly after noncurative ESD for EGC.